nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—SLC22A5—Valproic Acid—epilepsy syndrome	0.0745	1	CbGbCtD
Cefdinir—MPO—Folate Metabolism—FOLR1—epilepsy syndrome	0.0058	0.0307	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SEPW1—epilepsy syndrome	0.00541	0.0287	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PNPO—epilepsy syndrome	0.00375	0.0199	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00283	0.015	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00276	0.0146	CbGpPWpGaD
Cefdinir—Ceftriaxone—GLUL—epilepsy syndrome	0.00269	0.672	CrCbGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.00263	0.0139	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00259	0.0137	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.00256	0.0136	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00253	0.0134	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.0024	0.0127	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00235	0.0124	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.00235	0.0124	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.00218	0.0115	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00215	0.0114	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00215	0.0114	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.00205	0.0108	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.002	0.0106	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.00199	0.0105	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.00199	0.0105	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.00194	0.0103	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.0019	0.0101	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.00185	0.00981	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CASP6—epilepsy syndrome	0.00185	0.00981	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—SOCS3—epilepsy syndrome	0.00185	0.00981	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—PLAT—epilepsy syndrome	0.00178	0.00943	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL18—epilepsy syndrome	0.00169	0.00894	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00163	0.00861	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00163	0.00861	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00151	0.00799	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00151	0.00799	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00149	0.00788	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—PLAT—epilepsy syndrome	0.00145	0.00767	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00138	0.00732	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.00138	0.00731	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—epilepsy syndrome	0.00129	0.00683	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.00128	0.0068	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00127	0.0067	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00127	0.0067	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00127	0.0067	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00122	0.00645	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00118	0.00623	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00117	0.00622	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00117	0.00622	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00117	0.00622	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—CCL2—epilepsy syndrome	0.00116	0.00616	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00116	0.00613	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.00116	0.00612	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.00116	0.00612	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.00116	0.00612	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PLAT—epilepsy syndrome	0.00115	0.00609	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.00113	0.00598	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CAT—epilepsy syndrome	0.00112	0.00594	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CRP—epilepsy syndrome	0.00109	0.00579	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.00109	0.00578	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00107	0.00569	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—APOE—epilepsy syndrome	0.00107	0.00567	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.00106	0.00559	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—GPX1—epilepsy syndrome	0.00101	0.00537	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—RELA—epilepsy syndrome	0.000977	0.00517	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000959	0.00508	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000959	0.00508	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000959	0.00508	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—epilepsy syndrome	0.000941	0.00498	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000915	0.00485	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	0.0009	0.00477	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CAT—epilepsy syndrome	0.000891	0.00472	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CRP—epilepsy syndrome	0.000891	0.00471	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.00089	0.00471	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.00089	0.00471	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.00089	0.00471	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL1B—epilepsy syndrome	0.000883	0.00467	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—HES1—epilepsy syndrome	0.000879	0.00465	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000876	0.00464	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000876	0.00464	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000876	0.00464	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000849	0.0045	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—epilepsy syndrome	0.000839	0.00444	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000835	0.00442	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—GPX1—epilepsy syndrome	0.000806	0.00427	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—RELA—epilepsy syndrome	0.000755	0.004	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000746	0.00395	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CCL2—epilepsy syndrome	0.000733	0.00388	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000727	0.00385	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000727	0.00385	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000722	0.00382	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000722	0.00382	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CRP—epilepsy syndrome	0.000708	0.00375	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000692	0.00367	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	0.000683	0.00361	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—epilepsy syndrome	0.000683	0.00361	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000681	0.00361	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000675	0.00357	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000675	0.00357	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.00067	0.00355	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.00067	0.00355	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000665	0.00352	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000664	0.00351	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000664	0.00351	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000659	0.00349	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000659	0.00349	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000643	0.00341	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000643	0.00341	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000643	0.00341	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—epilepsy syndrome	0.000641	0.00339	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000618	0.00327	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000617	0.00327	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—RELA—epilepsy syndrome	0.000615	0.00325	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000607	0.00321	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000597	0.00316	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000597	0.00316	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000597	0.00316	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000588	0.00311	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000587	0.00311	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000587	0.00311	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000587	0.00311	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CCL2—epilepsy syndrome	0.000582	0.00308	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000574	0.00304	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000564	0.00299	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL1B—epilepsy syndrome	0.000556	0.00294	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000546	0.00289	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000544	0.00288	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—epilepsy syndrome	0.000542	0.00287	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000537	0.00284	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000526	0.00278	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—BCL2—epilepsy syndrome	0.000518	0.00274	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000514	0.00272	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000505	0.00267	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000497	0.00263	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—epilepsy syndrome	0.000496	0.00262	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PTGS2—epilepsy syndrome	0.000492	0.00261	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—RELA—epilepsy syndrome	0.000488	0.00258	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000488	0.00258	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000488	0.00258	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000488	0.00258	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000488	0.00258	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.00048	0.00254	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000477	0.00253	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	0.000474	0.00251	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000469	0.00248	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000469	0.00248	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000465	0.00246	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000465	0.00246	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000452	0.0024	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000452	0.0024	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000452	0.0024	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000445	0.00236	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000445	0.00236	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000445	0.00236	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL1B—epilepsy syndrome	0.000441	0.00234	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000435	0.0023	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000432	0.00228	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000432	0.00228	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000428	0.00226	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000425	0.00225	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000425	0.00225	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—epilepsy syndrome	0.000403	0.00213	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000379	0.00201	CbGpPWpGaD
Cefdinir—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000371	0.000506	CcSEcCtD
Cefdinir—Flatulence—Pregabalin—epilepsy syndrome	0.00037	0.000505	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.00037	0.00196	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.00037	0.00196	CbGpPWpGaD
Cefdinir—Dizziness—Midazolam—epilepsy syndrome	0.000369	0.000503	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000368	0.000503	CcSEcCtD
Cefdinir—Abdominal pain—Clonazepam—epilepsy syndrome	0.000368	0.000502	CcSEcCtD
Cefdinir—Body temperature increased—Clonazepam—epilepsy syndrome	0.000368	0.000502	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.000367	0.000502	CcSEcCtD
Cefdinir—Pruritus—Vigabatrin—epilepsy syndrome	0.000366	0.0005	CcSEcCtD
Cefdinir—Asthenia—Diazepam—epilepsy syndrome	0.000366	0.000499	CcSEcCtD
Cefdinir—Body temperature increased—Phenytoin—epilepsy syndrome	0.000366	0.000499	CcSEcCtD
Cefdinir—Constipation—Lamotrigine—epilepsy syndrome	0.000365	0.000498	CcSEcCtD
Cefdinir—Renal failure—Topiramate—epilepsy syndrome	0.000364	0.000497	CcSEcCtD
Cefdinir—Nausea—Acetazolamide—epilepsy syndrome	0.000364	0.000497	CcSEcCtD
Cefdinir—Dizziness—Levetiracetam—epilepsy syndrome	0.000364	0.000497	CcSEcCtD
Cefdinir—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000364	0.000496	CcSEcCtD
Cefdinir—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000364	0.000496	CcSEcCtD
Cefdinir—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000363	0.000496	CcSEcCtD
Cefdinir—Vomiting—Propofol—epilepsy syndrome	0.000362	0.000494	CcSEcCtD
Cefdinir—Stomatitis—Topiramate—epilepsy syndrome	0.000361	0.000493	CcSEcCtD
Cefdinir—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000361	0.000493	CcSEcCtD
Cefdinir—Pruritus—Diazepam—epilepsy syndrome	0.000361	0.000492	CcSEcCtD
Cefdinir—Conjunctivitis—Topiramate—epilepsy syndrome	0.00036	0.000492	CcSEcCtD
Cefdinir—Rash—Propofol—epilepsy syndrome	0.000359	0.00049	CcSEcCtD
Cefdinir—Dermatitis—Propofol—epilepsy syndrome	0.000359	0.00049	CcSEcCtD
Cefdinir—Hypertension—Valproic Acid—epilepsy syndrome	0.000359	0.000489	CcSEcCtD
Cefdinir—Headache—Propofol—epilepsy syndrome	0.000357	0.000487	CcSEcCtD
Cefdinir—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000356	0.000486	CcSEcCtD
Cefdinir—Vomiting—Midazolam—epilepsy syndrome	0.000354	0.000484	CcSEcCtD
Cefdinir—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000354	0.000484	CcSEcCtD
Cefdinir—Asthenia—Felbamate—epilepsy syndrome	0.000354	0.000483	CcSEcCtD
Cefdinir—Chest pain—Valproic Acid—epilepsy syndrome	0.000354	0.000483	CcSEcCtD
Cefdinir—Haematuria—Topiramate—epilepsy syndrome	0.000353	0.000482	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000352	0.00187	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000352	0.00186	CbGpPWpGaD
Cefdinir—Rash—Midazolam—epilepsy syndrome	0.000351	0.00048	CcSEcCtD
Cefdinir—Dizziness—Fosphenytoin—epilepsy syndrome	0.000351	0.00048	CcSEcCtD
Cefdinir—Dermatitis—Midazolam—epilepsy syndrome	0.000351	0.000479	CcSEcCtD
Cefdinir—Vomiting—Levetiracetam—epilepsy syndrome	0.00035	0.000478	CcSEcCtD
Cefdinir—Headache—Midazolam—epilepsy syndrome	0.000349	0.000477	CcSEcCtD
Cefdinir—Pruritus—Felbamate—epilepsy syndrome	0.000349	0.000476	CcSEcCtD
Cefdinir—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000349	0.000476	CcSEcCtD
Cefdinir—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000349	0.000476	CcSEcCtD
Cefdinir—Diarrhoea—Diazepam—epilepsy syndrome	0.000349	0.000476	CcSEcCtD
Cefdinir—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000349	0.000476	CcSEcCtD
Cefdinir—Rash—Levetiracetam—epilepsy syndrome	0.000347	0.000474	CcSEcCtD
Cefdinir—Dermatitis—Levetiracetam—epilepsy syndrome	0.000347	0.000473	CcSEcCtD
Cefdinir—Asthenia—Zonisamide—epilepsy syndrome	0.000347	0.000473	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000346	0.00183	CbGpPWpGaD
Cefdinir—Agranulocytosis—Topiramate—epilepsy syndrome	0.000346	0.000472	CcSEcCtD
Cefdinir—Dry mouth—Valproic Acid—epilepsy syndrome	0.000346	0.000472	CcSEcCtD
Cefdinir—Agitation—Pregabalin—epilepsy syndrome	0.000345	0.000471	CcSEcCtD
Cefdinir—Headache—Levetiracetam—epilepsy syndrome	0.000345	0.000471	CcSEcCtD
Cefdinir—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000343	0.000468	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000343	0.00182	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000343	0.00182	CbGpPWpGaD
Cefdinir—Dizziness—Vigabatrin—epilepsy syndrome	0.000342	0.000467	CcSEcCtD
Cefdinir—Pruritus—Zonisamide—epilepsy syndrome	0.000342	0.000466	CcSEcCtD
Cefdinir—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000341	0.000465	CcSEcCtD
Cefdinir—Flatulence—Gabapentin—epilepsy syndrome	0.000339	0.000463	CcSEcCtD
Cefdinir—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000339	0.000463	CcSEcCtD
Cefdinir—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000339	0.000463	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000339	0.00179	CbGpPWpGaD
Cefdinir—Nausea—Propofol—epilepsy syndrome	0.000338	0.000462	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000338	0.00179	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000338	0.00179	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000338	0.00179	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000338	0.00179	CbGpPWpGaD
Cefdinir—Vomiting—Fosphenytoin—epilepsy syndrome	0.000338	0.000461	CcSEcCtD
Cefdinir—Diarrhoea—Felbamate—epilepsy syndrome	0.000338	0.000461	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000337	0.00179	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000337	0.00179	CbGpPWpGaD
Cefdinir—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000337	0.00046	CcSEcCtD
Cefdinir—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000337	0.00046	CcSEcCtD
Cefdinir—Dizziness—Diazepam—epilepsy syndrome	0.000337	0.00046	CcSEcCtD
Cefdinir—Leukopenia—Pregabalin—epilepsy syndrome	0.000336	0.000459	CcSEcCtD
Cefdinir—Rash—Fosphenytoin—epilepsy syndrome	0.000335	0.000457	CcSEcCtD
Cefdinir—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000335	0.000457	CcSEcCtD
Cefdinir—Haemoglobin—Topiramate—epilepsy syndrome	0.000334	0.000456	CcSEcCtD
Cefdinir—Asthenia—Clonazepam—epilepsy syndrome	0.000334	0.000456	CcSEcCtD
Cefdinir—Headache—Fosphenytoin—epilepsy syndrome	0.000333	0.000454	CcSEcCtD
Cefdinir—Haemorrhage—Topiramate—epilepsy syndrome	0.000333	0.000454	CcSEcCtD
Cefdinir—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000332	0.000453	CcSEcCtD
Cefdinir—Asthenia—Phenytoin—epilepsy syndrome	0.000332	0.000453	CcSEcCtD
Cefdinir—Nausea—Midazolam—epilepsy syndrome	0.000331	0.000452	CcSEcCtD
Cefdinir—Diarrhoea—Zonisamide—epilepsy syndrome	0.00033	0.000451	CcSEcCtD
Cefdinir—Loss of consciousness—Pregabalin—epilepsy syndrome	0.00033	0.00045	CcSEcCtD
Cefdinir—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00033	0.00045	CcSEcCtD
Cefdinir—Pruritus—Clonazepam—epilepsy syndrome	0.000329	0.00045	CcSEcCtD
Cefdinir—Vomiting—Vigabatrin—epilepsy syndrome	0.000329	0.000449	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000327	0.00173	CbGpPWpGaD
Cefdinir—Pruritus—Phenytoin—epilepsy syndrome	0.000327	0.000447	CcSEcCtD
Cefdinir—Nausea—Levetiracetam—epilepsy syndrome	0.000327	0.000446	CcSEcCtD
Cefdinir—Rash—Vigabatrin—epilepsy syndrome	0.000327	0.000446	CcSEcCtD
Cefdinir—Dizziness—Felbamate—epilepsy syndrome	0.000326	0.000445	CcSEcCtD
Cefdinir—Dermatitis—Vigabatrin—epilepsy syndrome	0.000326	0.000445	CcSEcCtD
Cefdinir—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000325	0.000444	CcSEcCtD
Cefdinir—Convulsion—Pregabalin—epilepsy syndrome	0.000325	0.000444	CcSEcCtD
Cefdinir—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000325	0.000444	CcSEcCtD
Cefdinir—Headache—Vigabatrin—epilepsy syndrome	0.000324	0.000443	CcSEcCtD
Cefdinir—Hypertension—Pregabalin—epilepsy syndrome	0.000324	0.000442	CcSEcCtD
Cefdinir—Vomiting—Diazepam—epilepsy syndrome	0.000324	0.000442	CcSEcCtD
Cefdinir—Anorexia—Valproic Acid—epilepsy syndrome	0.000323	0.000441	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000322	0.0017	CbGpPWpGaD
Cefdinir—Rash—Diazepam—epilepsy syndrome	0.000321	0.000439	CcSEcCtD
Cefdinir—Dermatitis—Diazepam—epilepsy syndrome	0.000321	0.000438	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—epilepsy syndrome	0.00032	0.0017	CbGpPWpGaD
Cefdinir—Chest pain—Pregabalin—epilepsy syndrome	0.00032	0.000436	CcSEcCtD
Cefdinir—Dizziness—Zonisamide—epilepsy syndrome	0.000319	0.000436	CcSEcCtD
Cefdinir—Headache—Diazepam—epilepsy syndrome	0.000319	0.000436	CcSEcCtD
Cefdinir—Diarrhoea—Clonazepam—epilepsy syndrome	0.000318	0.000435	CcSEcCtD
Cefdinir—Asthenia—Carbamazepine—epilepsy syndrome	0.000317	0.000432	CcSEcCtD
Cefdinir—Agitation—Gabapentin—epilepsy syndrome	0.000316	0.000432	CcSEcCtD
Cefdinir—Diarrhoea—Phenytoin—epilepsy syndrome	0.000316	0.000432	CcSEcCtD
Cefdinir—Nausea—Fosphenytoin—epilepsy syndrome	0.000316	0.000431	CcSEcCtD
Cefdinir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000315	0.00043	CcSEcCtD
Cefdinir—Erythema multiforme—Topiramate—epilepsy syndrome	0.000315	0.000429	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000314	0.00166	CbGpPWpGaD
Cefdinir—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000314	0.000429	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000314	0.00166	CbGpPWpGaD
Cefdinir—Vomiting—Felbamate—epilepsy syndrome	0.000314	0.000428	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000314	0.00166	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000314	0.00166	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000314	0.00166	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000314	0.00166	CbGpPWpGaD
Cefdinir—Dry mouth—Pregabalin—epilepsy syndrome	0.000313	0.000427	CcSEcCtD
Cefdinir—Pruritus—Carbamazepine—epilepsy syndrome	0.000312	0.000426	CcSEcCtD
Cefdinir—Rash—Felbamate—epilepsy syndrome	0.000311	0.000425	CcSEcCtD
Cefdinir—Dermatitis—Felbamate—epilepsy syndrome	0.000311	0.000424	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000309	0.00164	CbGpPWpGaD
Cefdinir—Headache—Felbamate—epilepsy syndrome	0.000309	0.000422	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000308	0.00163	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000308	0.00163	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000308	0.00163	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000308	0.00163	CbGpPWpGaD
Cefdinir—Leukopenia—Gabapentin—epilepsy syndrome	0.000308	0.000421	CcSEcCtD
Cefdinir—Dizziness—Clonazepam—epilepsy syndrome	0.000308	0.00042	CcSEcCtD
Cefdinir—Nausea—Vigabatrin—epilepsy syndrome	0.000308	0.00042	CcSEcCtD
Cefdinir—Vomiting—Zonisamide—epilepsy syndrome	0.000307	0.000419	CcSEcCtD
Cefdinir—Insomnia—Valproic Acid—epilepsy syndrome	0.000307	0.000418	CcSEcCtD
Cefdinir—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000306	0.000418	CcSEcCtD
Cefdinir—Asthenia—Lamotrigine—epilepsy syndrome	0.000306	0.000418	CcSEcCtD
Cefdinir—Dizziness—Phenytoin—epilepsy syndrome	0.000306	0.000417	CcSEcCtD
Cefdinir—Rash—Zonisamide—epilepsy syndrome	0.000305	0.000416	CcSEcCtD
Cefdinir—Dermatitis—Zonisamide—epilepsy syndrome	0.000304	0.000415	CcSEcCtD
Cefdinir—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000304	0.000415	CcSEcCtD
Cefdinir—Nausea—Diazepam—epilepsy syndrome	0.000303	0.000413	CcSEcCtD
Cefdinir—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000303	0.000413	CcSEcCtD
Cefdinir—Headache—Zonisamide—epilepsy syndrome	0.000303	0.000413	CcSEcCtD
Cefdinir—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000302	0.000412	CcSEcCtD
Cefdinir—Pruritus—Lamotrigine—epilepsy syndrome	0.000302	0.000412	CcSEcCtD
Cefdinir—Shock—Pregabalin—epilepsy syndrome	0.000301	0.000411	CcSEcCtD
Cefdinir—Somnolence—Valproic Acid—epilepsy syndrome	0.000301	0.000411	CcSEcCtD
Cefdinir—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.0003	0.00041	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.0003	0.00159	CbGpPWpGaD
Cefdinir—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000298	0.000407	CcSEcCtD
Cefdinir—Convulsion—Gabapentin—epilepsy syndrome	0.000298	0.000407	CcSEcCtD
Cefdinir—Hypertension—Gabapentin—epilepsy syndrome	0.000297	0.000406	CcSEcCtD
Cefdinir—Vomiting—Clonazepam—epilepsy syndrome	0.000296	0.000404	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000295	0.00156	CbGpPWpGaD
Cefdinir—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000295	0.000402	CcSEcCtD
Cefdinir—Vomiting—Phenytoin—epilepsy syndrome	0.000294	0.000401	CcSEcCtD
Cefdinir—Rash—Clonazepam—epilepsy syndrome	0.000293	0.000401	CcSEcCtD
Cefdinir—Dermatitis—Clonazepam—epilepsy syndrome	0.000293	0.0004	CcSEcCtD
Cefdinir—Chest pain—Gabapentin—epilepsy syndrome	0.000293	0.0004	CcSEcCtD
Cefdinir—Nausea—Felbamate—epilepsy syndrome	0.000293	0.0004	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000293	0.000399	CcSEcCtD
Cefdinir—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000292	0.000399	CcSEcCtD
Cefdinir—Anorexia—Pregabalin—epilepsy syndrome	0.000292	0.000399	CcSEcCtD
Cefdinir—Dizziness—Carbamazepine—epilepsy syndrome	0.000292	0.000398	CcSEcCtD
Cefdinir—Cephalexin—CYP2D6—epilepsy syndrome	0.000292	0.0728	CrCbGaD
Cefdinir—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000292	0.000398	CcSEcCtD
Cefdinir—Headache—Clonazepam—epilepsy syndrome	0.000292	0.000398	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000292	0.00154	CbGpPWpGaD
Cefdinir—Rash—Phenytoin—epilepsy syndrome	0.000292	0.000398	CcSEcCtD
Cefdinir—Dermatitis—Phenytoin—epilepsy syndrome	0.000291	0.000398	CcSEcCtD
Cefdinir—Rash—Oxcarbazepine—epilepsy syndrome	0.00029	0.000396	CcSEcCtD
Cefdinir—Constipation—Valproic Acid—epilepsy syndrome	0.00029	0.000396	CcSEcCtD
Cefdinir—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00029	0.000395	CcSEcCtD
Cefdinir—Headache—Phenytoin—epilepsy syndrome	0.00029	0.000395	CcSEcCtD
Cefdinir—Cefazolin—ALB—epilepsy syndrome	0.000289	0.0722	CrCbGaD
Cefdinir—Headache—Oxcarbazepine—epilepsy syndrome	0.000288	0.000393	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000287	0.00152	CbGpPWpGaD
Cefdinir—Nausea—Zonisamide—epilepsy syndrome	0.000287	0.000392	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000287	0.00152	CbGpPWpGaD
Cefdinir—Dry mouth—Gabapentin—epilepsy syndrome	0.000287	0.000391	CcSEcCtD
Cefdinir—Flatulence—Topiramate—epilepsy syndrome	0.000285	0.00039	CcSEcCtD
Cefdinir—Dizziness—Lamotrigine—epilepsy syndrome	0.000282	0.000385	CcSEcCtD
Cefdinir—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000281	0.000384	CcSEcCtD
Cefdinir—Vomiting—Carbamazepine—epilepsy syndrome	0.000281	0.000383	CcSEcCtD
Cefdinir—Rash—Carbamazepine—epilepsy syndrome	0.000278	0.00038	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000278	0.00147	CbGpPWpGaD
Cefdinir—Dermatitis—Carbamazepine—epilepsy syndrome	0.000278	0.000379	CcSEcCtD
Cefdinir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000277	0.000378	CcSEcCtD
Cefdinir—Insomnia—Pregabalin—epilepsy syndrome	0.000277	0.000378	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000277	0.00146	CbGpPWpGaD
Cefdinir—Nausea—Clonazepam—epilepsy syndrome	0.000276	0.000377	CcSEcCtD
Cefdinir—Headache—Carbamazepine—epilepsy syndrome	0.000276	0.000377	CcSEcCtD
Cefdinir—Shock—Gabapentin—epilepsy syndrome	0.000276	0.000377	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000276	0.00146	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000275	0.000376	CcSEcCtD
Cefdinir—Nausea—Phenytoin—epilepsy syndrome	0.000275	0.000375	CcSEcCtD
Cefdinir—Ceftriaxone—ALB—epilepsy syndrome	0.000274	0.0684	CrCbGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.000274	0.00145	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	0.000274	0.00145	CbGpPWpGaD
Cefdinir—Nausea—Oxcarbazepine—epilepsy syndrome	0.000273	0.000373	CcSEcCtD
Cefdinir—Somnolence—Pregabalin—epilepsy syndrome	0.000272	0.000372	CcSEcCtD
Cefdinir—Vomiting—Lamotrigine—epilepsy syndrome	0.000271	0.00037	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	0.00027	0.00143	CbGpPWpGaD
Cefdinir—Rash—Lamotrigine—epilepsy syndrome	0.000269	0.000367	CcSEcCtD
Cefdinir—Dermatitis—Lamotrigine—epilepsy syndrome	0.000269	0.000367	CcSEcCtD
Cefdinir—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000268	0.000366	CcSEcCtD
Cefdinir—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000268	0.000366	CcSEcCtD
Cefdinir—Anorexia—Gabapentin—epilepsy syndrome	0.000268	0.000366	CcSEcCtD
Cefdinir—Headache—Lamotrigine—epilepsy syndrome	0.000267	0.000365	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000267	0.00141	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000267	0.00141	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000267	0.00141	CbGpPWpGaD
Cefdinir—Decreased appetite—Pregabalin—epilepsy syndrome	0.000266	0.000364	CcSEcCtD
Cefdinir—Agitation—Topiramate—epilepsy syndrome	0.000266	0.000363	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000265	0.000361	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	0.000262	0.00139	CbGpPWpGaD
Cefdinir—Nausea—Carbamazepine—epilepsy syndrome	0.000262	0.000358	CcSEcCtD
Cefdinir—Constipation—Pregabalin—epilepsy syndrome	0.000262	0.000358	CcSEcCtD
Cefdinir—Leukopenia—Topiramate—epilepsy syndrome	0.000259	0.000354	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000257	0.00136	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000256	0.00136	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000256	0.00136	CbGpPWpGaD
Cefdinir—Loss of consciousness—Topiramate—epilepsy syndrome	0.000255	0.000347	CcSEcCtD
Cefdinir—Insomnia—Gabapentin—epilepsy syndrome	0.000254	0.000347	CcSEcCtD
Cefdinir—Nausea—Lamotrigine—epilepsy syndrome	0.000253	0.000346	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	0.000252	0.00134	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	0.000252	0.00133	CbGpPWpGaD
Cefdinir—Convulsion—Topiramate—epilepsy syndrome	0.000251	0.000343	CcSEcCtD
Cefdinir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000251	0.000342	CcSEcCtD
Cefdinir—Hypertension—Topiramate—epilepsy syndrome	0.00025	0.000341	CcSEcCtD
Cefdinir—Somnolence—Gabapentin—epilepsy syndrome	0.00025	0.000341	CcSEcCtD
Cefdinir—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.00025	0.000341	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000248	0.00131	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000248	0.00131	CbGpPWpGaD
Cefdinir—Dyspepsia—Gabapentin—epilepsy syndrome	0.000247	0.000338	CcSEcCtD
Cefdinir—Chest pain—Topiramate—epilepsy syndrome	0.000247	0.000337	CcSEcCtD
Cefdinir—Decreased appetite—Gabapentin—epilepsy syndrome	0.000244	0.000333	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	0.000244	0.00129	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	0.000244	0.00129	CbGpPWpGaD
Cefdinir—Asthenia—Valproic Acid—epilepsy syndrome	0.000243	0.000332	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000243	0.000331	CcSEcCtD
Cefdinir—Body temperature increased—Pregabalin—epilepsy syndrome	0.000242	0.000331	CcSEcCtD
Cefdinir—Abdominal pain—Pregabalin—epilepsy syndrome	0.000242	0.000331	CcSEcCtD
Cefdinir—Dry mouth—Topiramate—epilepsy syndrome	0.000241	0.000329	CcSEcCtD
Cefdinir—Constipation—Gabapentin—epilepsy syndrome	0.00024	0.000328	CcSEcCtD
Cefdinir—Cefalotin—ALB—epilepsy syndrome	0.00024	0.0599	CrCbGaD
Cefdinir—Pruritus—Valproic Acid—epilepsy syndrome	0.00024	0.000327	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000238	0.00126	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000238	0.00126	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	0.000234	0.00124	CbGpPWpGaD
Cefdinir—Shock—Topiramate—epilepsy syndrome	0.000233	0.000317	CcSEcCtD
Cefdinir—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000232	0.000317	CcSEcCtD
Cefdinir—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000231	0.000316	CcSEcCtD
Cefdinir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00023	0.000314	CcSEcCtD
Cefdinir—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000226	0.000308	CcSEcCtD
Cefdinir—Anorexia—Topiramate—epilepsy syndrome	0.000225	0.000308	CcSEcCtD
Cefdinir—Dizziness—Valproic Acid—epilepsy syndrome	0.000224	0.000306	CcSEcCtD
Cefdinir—Body temperature increased—Gabapentin—epilepsy syndrome	0.000222	0.000303	CcSEcCtD
Cefdinir—Abdominal pain—Gabapentin—epilepsy syndrome	0.000222	0.000303	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000221	0.00117	CbGpPWpGaD
Cefdinir—Asthenia—Pregabalin—epilepsy syndrome	0.00022	0.0003	CcSEcCtD
Cefdinir—Cephalexin—ALB—epilepsy syndrome	0.000218	0.0545	CrCbGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000218	0.00115	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	0.000217	0.00115	CbGpPWpGaD
Cefdinir—Pruritus—Pregabalin—epilepsy syndrome	0.000217	0.000296	CcSEcCtD
Cefdinir—Vomiting—Valproic Acid—epilepsy syndrome	0.000216	0.000294	CcSEcCtD
Cefdinir—Insomnia—Topiramate—epilepsy syndrome	0.000214	0.000292	CcSEcCtD
Cefdinir—Rash—Valproic Acid—epilepsy syndrome	0.000214	0.000292	CcSEcCtD
Cefdinir—Dermatitis—Valproic Acid—epilepsy syndrome	0.000214	0.000291	CcSEcCtD
Cefdinir—Headache—Valproic Acid—epilepsy syndrome	0.000212	0.00029	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000212	0.00112	CbGpPWpGaD
Cefdinir—Somnolence—Topiramate—epilepsy syndrome	0.00021	0.000287	CcSEcCtD
Cefdinir—Diarrhoea—Pregabalin—epilepsy syndrome	0.00021	0.000286	CcSEcCtD
Cefdinir—Dyspepsia—Topiramate—epilepsy syndrome	0.000208	0.000284	CcSEcCtD
Cefdinir—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000207	0.000283	CcSEcCtD
Cefdinir—Decreased appetite—Topiramate—epilepsy syndrome	0.000205	0.00028	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000204	0.000279	CcSEcCtD
Cefdinir—Dizziness—Pregabalin—epilepsy syndrome	0.000203	0.000277	CcSEcCtD
Cefdinir—Constipation—Topiramate—epilepsy syndrome	0.000202	0.000276	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000202	0.00107	CbGpPWpGaD
Cefdinir—Asthenia—Gabapentin—epilepsy syndrome	0.000202	0.000275	CcSEcCtD
Cefdinir—Nausea—Valproic Acid—epilepsy syndrome	0.000201	0.000275	CcSEcCtD
Cefdinir—Pruritus—Gabapentin—epilepsy syndrome	0.000199	0.000271	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	0.000199	0.00105	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000197	0.00104	CbGpPWpGaD
Cefdinir—Vomiting—Pregabalin—epilepsy syndrome	0.000195	0.000266	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	0.000194	0.00103	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000193	0.000264	CcSEcCtD
Cefdinir—Rash—Pregabalin—epilepsy syndrome	0.000193	0.000264	CcSEcCtD
Cefdinir—Dermatitis—Pregabalin—epilepsy syndrome	0.000193	0.000263	CcSEcCtD
Cefdinir—Diarrhoea—Gabapentin—epilepsy syndrome	0.000192	0.000262	CcSEcCtD
Cefdinir—Headache—Pregabalin—epilepsy syndrome	0.000192	0.000262	CcSEcCtD
Cefdinir—Abdominal pain—Topiramate—epilepsy syndrome	0.000187	0.000255	CcSEcCtD
Cefdinir—Body temperature increased—Topiramate—epilepsy syndrome	0.000187	0.000255	CcSEcCtD
Cefdinir—Dizziness—Gabapentin—epilepsy syndrome	0.000186	0.000254	CcSEcCtD
Cefdinir—Nausea—Pregabalin—epilepsy syndrome	0.000182	0.000248	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.00018	0.000955	CbGpPWpGaD
Cefdinir—Vomiting—Gabapentin—epilepsy syndrome	0.000179	0.000244	CcSEcCtD
Cefdinir—Rash—Gabapentin—epilepsy syndrome	0.000177	0.000242	CcSEcCtD
Cefdinir—Dermatitis—Gabapentin—epilepsy syndrome	0.000177	0.000242	CcSEcCtD
Cefdinir—Headache—Gabapentin—epilepsy syndrome	0.000176	0.00024	CcSEcCtD
Cefdinir—Hypersensitivity—Topiramate—epilepsy syndrome	0.000174	0.000238	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000172	0.000911	CbGpPWpGaD
Cefdinir—Asthenia—Topiramate—epilepsy syndrome	0.00017	0.000232	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000167	0.000886	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000167	0.000886	CbGpPWpGaD
Cefdinir—Pruritus—Topiramate—epilepsy syndrome	0.000167	0.000228	CcSEcCtD
Cefdinir—Nausea—Gabapentin—epilepsy syndrome	0.000167	0.000228	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	0.000165	0.000872	CbGpPWpGaD
Cefdinir—Diarrhoea—Topiramate—epilepsy syndrome	0.000162	0.000221	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.00016	0.000846	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	0.000157	0.000832	CbGpPWpGaD
Cefdinir—Dizziness—Topiramate—epilepsy syndrome	0.000156	0.000213	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000155	0.000822	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	0.000153	0.000808	CbGpPWpGaD
Cefdinir—Vomiting—Topiramate—epilepsy syndrome	0.00015	0.000205	CcSEcCtD
Cefdinir—Rash—Topiramate—epilepsy syndrome	0.000149	0.000203	CcSEcCtD
Cefdinir—Dermatitis—Topiramate—epilepsy syndrome	0.000149	0.000203	CcSEcCtD
Cefdinir—Headache—Topiramate—epilepsy syndrome	0.000148	0.000202	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000142	0.00075	CbGpPWpGaD
Cefdinir—Nausea—Topiramate—epilepsy syndrome	0.00014	0.000192	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.00014	0.000743	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000136	0.000719	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000131	0.000696	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.00013	0.000689	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	0.000129	0.000684	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	0.000128	0.000678	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000126	0.000668	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	0.000124	0.000657	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.5e-05	0.00045	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.89e-05	0.000418	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.76e-05	0.000411	CbGpPWpGaD
